|Brenntag AG -- USA Stock|| |
USD 55.42 6.88 11.05%
Member of the Supervisory Board
Age: 67 Executive Since 2010 Ph.D
49 208 7828 0 http://www.brenntag.com
Edgar Fluri is Member of the Supervisory Board of Brenntag AG since March 28, 2010. He spent his professional career with PricewaterhouseCoopers Switzerland where he was a Partner, Deputy Chairman and Chairman of the Management Committee, and from 1998 to 2008, Chairman of the Board of Directors. He was also Member of the Global Board of PricewaterhouseCoopers. Since 2008, he was active as business advisor and besides Brenntag AG, now holds mandates as Member of the Board of Directors at Galerie Beyeler AG, Nobel Biocare Holding AG till December 11, 2014, Orior AG and Bank La Roche & Co. AG since April 1, 2014. He was a parttime lecturer in public accounting and auditing at the University of Basel since 1987 and was appointed titular professor in 1997. He is a Swiss Certified Public Accountant and has a Doctorate in Economics and Business Administration from Universitaet Basel.
The company has return on total asset (ROA)
of 5.57 %
which means that it generated profit of $5.57 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 14.1 %
meaning that it generated $14.1 on every $100 dollars invested by stockholders.
The company has accumulated 3.25 B in total debt with debt to equity ratio (D/E) of 89.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Brenntag AG has Current Ratio of 1.4 which is within standard range for the sector.
Brenntag AG, a chemical distribution company, provides distribution solutions for industrial and specialty chemicals worldwide. The company was founded in 1874 and is headquartered in Mlheim an der Ruhr, Germany. Brenntag AG is traded on OTC Market in USA.Brenntag AG (BNTGF) is traded on OTC Market in USA. It is located in Stinnes-Platz 1 and employs 15,085 people.